Cargando…
Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
BACKGROUND: Weekly paclitaxel (wPTX) is the preferred second-line chemotherapy for gastric cancer in Japan. Histone deacetylase inhibitors have been shown to decrease proliferation through cell-cycle arrest, differentiation, and apoptosis in gastric cancer cells. One histone deacetylase inhibitor, v...
Autores principales: | Fushida, Sachio, Kinoshita, Jun, Kaji, Masahide, Oyama, Katsunobu, Hirono, Yasuo, Tsukada, Tomoya, Fujimura, Takashi, Ohta, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966651/ https://www.ncbi.nlm.nih.gov/pubmed/27524882 http://dx.doi.org/10.2147/DDDT.S110425 |
Ejemplares similares
-
Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
por: Fushida, Sachio, et al.
Publicado: (2015) -
A randomized controlled trial of postoperative intravenous acetaminophen plus thoracic epidural analgesia vs. thoracic epidural analgesia alone after gastrectomy for gastric cancer
por: Kinoshita, Jun, et al.
Publicado: (2018) -
Low-dose paclitaxel modulates tumour fibrosis in gastric cancer
por: TSUKADA, TOMOYA, et al.
Publicado: (2013) -
Arandomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease
por: Fushida, Sachio, et al.
Publicado: (2015) -
Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy
por: Fushida, Sachio, et al.
Publicado: (2018)